Vasculonics, Inc.
We have developed a novel, disease-modifying therapy for pulmonary arterial hypertension, a severe disease that most commonly affects women between 30 and 60.
- Stage Product In Development
- Industry Biotechnology
- Location Indianapolis, IN, USA
- Currency USD
- Founded July 2020
- Employees 4
- Incorporation Type C-corp
- Website vasculonics.com
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.